Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Mahmoud: Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate.... (0.08 sec) 

Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the …

- nih.gov
TH Mahmoud, YW Peng, AD Proia, M Davidson … - British Journal of Ophthalmology, 2006 - bjo.bmj.com
Results: After reperfusion, the clinical picture was similar to that of a
central retinal vein occlusion. Immunoperoxidase staining showed rtPA only in
the retinal veins but not the retinal arteries in all eyes injected with ...
Cited by 4 - Related articles - BL Direct - All 7 versions

Intravitreal recombinant tissue plasminogen activator (rt-PA) in experimental retinal vein …


MB Nehemy, E Passos - Investigative Ophtalmology and Visual Science, 2002 - ARVO
Purpose: To evaluate the efficacy of intravitreal rt-PA in promoting patency of
the vessels and resolution of intraretinal hemorrhages in photochemically
induced retinal vein occlusion in rabbits. Methods: Occlusion of the ...
Cited by 1 - Related articles

What is the role of vitrectomy for macular edema from branch retinal vein occlusion?


JT Thompson - American journal of ophthalmology, 2004 - Elsevier
In the article by yamamoto and associates, 1 treatment for macular edema
secondary to branch retinal vein occlusion is discussed. The treatment of
macular edema from a variety of retinal vascular etiologies such as venous ...
Cited by 2 - Related articles - All 10 versions

Lack of effectiveness of tissue plasminogen activator 20 or more days after vitrectomy


JC Folk, JM Hershey, MB Rivers - Archives of Ophthalmology, 1991 - archopht.highwire.org
50 mg/kg per day, in a single dose for 7 days is the recommend¬ ed treatment
for the disease in infants. Spectinomycin hydro- chloride remains the drug of
choice for children and adults sensitive to ß-lactam antibiotics.5 ...
Cited by 10 - Related articles - All 4 versions

[CITATION] Intravitreal distribution of tissue plasminogen activator in nonvitrectomized and fibrin-filled …


BC Egana, CR LaPuente, GA Peyman, AM … - Invest Ophthalmol Vis Sci, 1997
Cited by 3 - Related articles

[CITATION] Sequential treatment of central retinal vein occlusion with intravitreal tissue plasminogen …


JM Lahey, JJ Kearney, MC Cheung - The British journal of ophthalmology, 2004 - ncbi.nlm.nih.gov
1: Br J Ophthalmol. 2004 Aug;88(8):1100-1. Erratum in: Br J Ophthalmol. 2004
Oct;88(10):1355. Sequential treatment of central retinal ...
Cited by 4 - Related articles

Intravitreal and subretinal injection of tissue plasminogen activator (tpa) in the treatment of …


H Ameri, JG Kim, T Ratanapakorn, GJ … - Retina, 2008 - journals.lww.com
From *Doheny Retina Institute, Doheny Eye Institute, Department of
Ophthalmology, Keck School of Medicine, University of Southern California, Los
Angeles; †Department of Ophthalmology, Asan Medical Center, University of ...
Cited by 1 - Related articles - BL Direct - All 4 versions

t-PA in CRVO


SS Hayreh - Ophthalmology, 2002 - Elsevier
I was interested to read the article by Weiss and Bynoe[1] claiming that
vitrectomy with branch retinal vein cannulation and infusion of tissue
plasminogen activator (t-PA) in 28 eyes with central retinal vein occlusion ...
Cited by 5 - Related articles - All 10 versions

Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion


JN Vallee, A Aymard, M Paques, PY Santiago, … - Journal de radiologie, 2001 - ncbi.nlm.nih.gov
PURPOSE: To assess the value of selective ophthalmic artery thrombolysis as a
treatment for central retinal vein occlusion (CRVO) for which no alternative
therapy is available. MATERIALS AND METHODS: Patients included in this ...
Cited by 6 - Related articles

Perfluorochemical oxygen carriers: potential uses in neurosciences.


DE Sakas, G Stranjalis, K Whittaker, HL … - Cerebrovascular and brain metabolism reviews, 1996 - ncbi.nlm.nih.gov
In this article we review recent developments in the field of "first-" and
"second-generation" perfluorochemical (PFC) oxygen carriers. Particular emphasis
is placed on the latest research and its implications regarding the ...
Cited by 6 - Related articles - BL Direct


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google